Woman, 22, Beats Rare Breast Cancer in 6 Months

When Shelby Bennoit found a lump in her breast at age 22, she never imagined it would be cancer. With no family history and her young age, doctors confirmed what seemed impossible: Stage 2b Triple Negative Breast Cancer, a diagnosis affecting just 0.1% of women under 25.

The Maryland woman faced her diagnosis with courage, immediately starting an aggressive treatment plan at Ascension Saint Agnes Hospital. She completed 16 rounds of chemotherapy, some weekly and others bi-weekly, each one bringing difficult side effects including hair loss and exhaustion.

"I was in shock for a very long time," Bennoit recalls. "It didn't really hit me until I started treatment and started experiencing those effects."

After chemotherapy, Bennoit chose a bilateral mastectomy to do everything possible to prevent the cancer from returning. Her surgical director, Dr. Kristen Fernandez, stayed by her side throughout the journey, calling with updates at all hours and answering every question.

The aggressive approach paid off. Just six months after her August 2023 diagnosis, Bennoit received the news she'd been fighting for: she was cancer-free.

"I had never felt such an elated, joyful feeling in my life," she says. "I was so grateful to my team here and my family and everyone that supported me through all of my trials and tribulations."

Why This Inspires

At just 24 years old, Bennoit is channeling her experience into hope for others. She's using National Cancer Survivors' Month to encourage young women to discuss risk factors with their doctors, even without family history.

Her message resonates beyond medical advice. Bennoit wants anyone facing a cancer diagnosis to know they're not alone, and that staying positive makes a difference even in the darkest moments.

"Please don't give up, try to stay as positive as possible," she urges. "Reach out for help when you need it. There are so many of us out there that are willing to hold your hand and walk you through this."

Bennoit's rapid recovery from an extremely rare cancer proves that early detection and aggressive treatment can work miracles, even when the odds seem impossible.